Literature DB >> 2542723

Insulin influences the renin-angiotensin-aldosterone system in humans.

M Trovati1, P Massucco, G Anfossi, F Cavalot, E Mularoni, L Mattiello, G Rocca, G Emanuelli.   

Abstract

This study investigates whether insulin influences the renin-angiotensin-aldosterone system in humans. Six healthy male volunteers were placed on a 30-minute euglycemic insulin clamp at 160 microU/mL; euglycemia was maintained also in the following 60 minutes by means of appropriate dextrose infusion. Throughout the study, plasma renin activity, angiotensin II, aldosterone, and factors involved in the regulation of the renin-angiotensin-aldosterone system were measured: catecholamines, angiotensin-converting enzyme, sodium, and potassium. A significant increase of plasma renin activity and angiotensin II was observed, and a decrease of aldosterone was also detected. These changes can be ascribed to the effects of the rapid insulin-induced plasma potassium decrease on plasma renin activity and aldosterone secretion because they did not occur in a control clamp study with a potassium infusion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542723     DOI: 10.1016/0026-0495(89)90207-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Hypoglycaemia increases aldosterone in a dose-dependent fashion.

Authors:  G K Adler; I Bonyhay; V Curren; E Waring; R Freeman
Journal:  Diabet Med       Date:  2010-11       Impact factor: 4.359

2.  Exogenous insulin augments in healthy volunteers the cardiovascular reactivity to noradrenaline but not to angiotensin II.

Authors:  R O Gans; H J Bilo; W W von Maarschalkerweerd; R J Heine; J J Nauta; A J Donker
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

3.  Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone.

Authors:  M Trovati; P Massucco; L Mattiello; F Cavalot; E Mularoni; A Hahn; G Anfossi
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.